CD44 and its v6 spliced variant in lung tumors: A role in histogenesis?

Cancer

Volumn 80, Issue 1, 1997, Pages 34-41

  Fasano, Maria ^a   Sabatini, Maria T ^b   Wieczorek, Rosemary ^c   Sidhu, Gurdip ^c   Goswami, Sunanda ^a   Jagirdar, Jaishree ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b CABRINI MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CD44v6; Histogenesis; Immunohistochemistry; Lung; Lung carcinoma; Prognosis

Indexed keywords

HERMES ANTIGEN;

ARTICLE; CANCER STAGING; CARCINOGENESIS; CARCINOID; FETUS; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS CELL CARCINOMA; LUNG TUMOR; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS; RNA SPLICING; SQUAMOUS CELL CARCINOMA;

ADULT; ANTIGENIC VARIATION; ANTIGENS, CD44; COLORING AGENTS; FETUS; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; PROGNOSIS;

EID: 0030947576     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970701)80:1<34::AID-CNCR5>3.0.CO;2-F     Document Type: Article

References (34)

1. Boring CC, Squires TS, Tong T. Cancer statistics, 1993. CA Cancer J Clin 1993;43:7-26.
2. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995;75:191-202.
3. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-13.
4. Shimizu Y, Van Seventer GA, Siraganian R, Wahl L, Shaw S. Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol 1989;143:2457-63.
5. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992;89:12160-4.
6. Mackay CR, Terpe H-J, Stauder R, Marston WL, Stark H, Gunthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994;124:71-82.
7. Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, et al. Normal human tissues, in addition to some tumors, multiple different CD44 isoforms. Cancer Res 1994;54:4539-46.
8. Joensuu H, Klemi PJ, Toikkanen S, Jalkanen S. Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 1993;143:867-74.
9. Jalkanen S, Joensuu H, Soderstrom K-O, Klemi P. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J Clin Invest 1991;87:1835-40.
10. Mayer B, Jauch KW, Gunthert U, Figdor CG, Schildberg FW, Funke I, et al. De-novo expression of CD44 and survival in gastric cancer. Lancet 1993;342:1019-22.
11. Wielenga VJM, Heider K-H, Offerhaus GJA, Adolf GR, van den Berg FM, Ponta H, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993;53:4754-6.
12. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussman I, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
13. Favrot MC, Combaret V, Lasset C. CD44 - a new prognostic marker for neuroblastoma. N Engl J Med 1993;329:1965.
14. Salmi M, Gron-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S. Regulated expression of exon v6 containing isoforms of CD44 in man. Downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 1993;122:431-42.
15. Penno MB, August JT, Baylin SB, Mabry M, Linnoila RI, Lee VS, et al. Expression of CD44 in human lung tumors. Cancer Res 1994;54:1381-7.
16. Washimi O, Ueda R, Ariyoshi Y, Suyama M, Seki T, Takahashi T, et al. Expression of CD44 variant isoforms in normal and neoplastic cells of the lung. Jpn J Cancer Res 1994;85:1112-6.
17. Jackson DG, Schenker T, Waibel R, Bell JI, Stahel RA. Expression of alternatively spliced forms of the CD44 extracellular - matrix receptor on human lung carcinomas. Int J Cancer 1994;58:110-5.
18. Clarke MR, Resnick NM, Landreneau RJ, Cooper DL. CD44 isoform expression in primary and metastatic lung tumors. Lab Invest 1995;72:137A.
19. Coppola D, Clarke MR, Landreneau RJ, Weyant RJ, Cooper DL, Yousem SA. bcl-2, p53, CD44 and CD44v6 expression in neuroendocrine tumors of the lung. Mod Pathol 1996;9:484-90.
20. Mountain CF. A new international staging system for lung cancer. Chest 1986;89(Suppl):225S-33S.
21. Wheatley SC, Isacke CM, Crossley PH. Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development 1993;119:295-306.
22. Ayroldi E, Cannarile L, Migliorati G, Bartoli A, Nicoletti I, Riccardi C. CD44 (Pgp-1) inhibits CDS and dexamethasone-induced apoptosis. Blood 1995;86:2672-8.
23. Hardingham TE, Fosang AJ. Proteoglycans: many terms and many functions. FASEB J 1992;6:861-70.
24. Auerbach O. Natural history of carcinoma of the lung. In: Fishman AP, editor. Pulmonary diseases and disorders. New York: McGraw-Hill, 1980:1388-96.
25. Yesner R. Spectrum of lung cancer and ectopic hormones, Pathol Annu 1978;13:217-40.
26. Sell S, Pierce GB. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 1994;70:6-22.
27. Rao SK, Fraire AE. Alveolar cell hyperplasia in association with adenocarcinoma of lung. Mod Pathol 1995;8:165-9.
28. Kerr KM, Carey FA, King G, Lamb D. Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression. J Pathol 1994;174:249-56.
29. Carey FA, Wallace WAR, Fergusson RJ, Kerr KM, Lamb D. Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases. Thorax 1992;47:1041-3.
30. Geller SA, Gordon SE. Peripheral spindle-cell carcinoid tumor of the lung with type II pneumocyte features. An ultrastructural study with comments on possible histogenesis. Am J Surg Pathol 1984;8:145-50.
31. Jin L, Hemperly JJ, Lloyd RV. Expression of neural cell adhesion molecule in normal and neoplastic human neuroendocrine tissues. Am J Pathol 1991;138:961-9.
32. Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 1993;68:4-17.
33. Pignatelli M, Vessey CJ. Adhesion molecules: novel molecular tools in tumor pathology. Hum Pathol 1994;25:849-56.
34. Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, et al. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 1995;60:471-7.